Female Reproductive System Endometrioid Adenocarcinoma

Female Reproductive System Endometrioid Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

111 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 20
Ph III recruiting: 6
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07078838	Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer	not yet recruiting	Phase 2	40	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Sep 28, 2026	clinicaltrials
NCT07812636	Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer(TIDE)	not yet recruiting	Early Phase 1	15	Milton S. Hershey Medical CenterOTHER	1	Sep 10, 2026